We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMHC
1001
DELISTED
Taylor Morrison
TMHC
$253K ﹤0.01%
+12,073
New +$240K
EV
1002
DELISTED
Eaton Vance Corp.
EV
$252K ﹤0.01%
+5,847
New +$239K
TTMI icon
1003
TTM Technologies
TTMI
$14.5B
$250K ﹤0.01%
24,500
+24,485
+163,233% +$271K
ARAY icon
1004
Accuray
ARAY
$34M
$249K ﹤0.01%
+64,333
New +$260K
BEAT
1005
DELISTED
BioTelemetry, Inc.
BEAT
$247K ﹤0.01%
+5,140
New +$270K
BEDU
1006
DELISTED
Bright Scholar Education Holdings
BEDU
$246K ﹤0.01%
6,774
-3,342
-33% -$142K
BURL icon
1007
Burlington
BURL
$23.2B
$246K ﹤0.01%
1,444
-35,190
-96% -$5.75M
NAV
1008
DELISTED
Navistar International
NAV
$245K ﹤0.01%
+7,114
New +$236K
MCHP icon
1009
Microchip Technology
MCHP
$46B
$242K ﹤0.01%
+5,586
New +$248K
GPI icon
1010
Group 1 Automotive
GPI
$3.18B
$238K ﹤0.01%
2,903
-8,715
-75% -$655K
CEQP
1011
DELISTED
Crestwood Equity Partners LP
CEQP
$235K ﹤0.01%
6,575
-10,811
-62% -$387K
COHU icon
1012
Cohu
COHU
$2.5B
$234K ﹤0.01%
+15,118
New +$235K
WTS icon
1013
Watts Water Technologies
WTS
$13.1B
$234K ﹤0.01%
2,515
+2,415
+2,415% +$206K
CMD
1014
DELISTED
Cantel Medical Corporation
CMD
$234K ﹤0.01%
2,900
+2,336
+414% +$164K
CRSP icon
1015
CRISPR Therapeutics
CRSP
$5.17B
$233K ﹤0.01%
+4,945
New +$198K
MINI
1016
DELISTED
Mobile Mini Inc
MINI
$232K ﹤0.01%
7,595
+1,400
+23% +$46.5K
TYPE
1017
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$232K ﹤0.01%
+13,737
New +$245K
ROP icon
1018
Roper Technologies
ROP
$39.8B
$227K ﹤0.01%
619
-43,396
-99% -$15.4M
PAHC icon
1019
Phibro Animal Health
PAHC
$1.39B
$226K ﹤0.01%
7,119
+786
+12% +$24.6K
QTTB icon
1020
Q32 Bio
QTTB
$464M
$226K ﹤0.01%
643
-4,530
-88% -$1.78M
STI
1021
DELISTED
SunTrust Banks, Inc.
STI
$226K ﹤0.01%
3,600
-3,722
-51% -$234K
OSW icon
1022
OneSpaWorld
OSW
$2.66B
$223K ﹤0.01%
14,358
-87,216
-86% -$1.2M
TREX icon
1023
Trex
TREX
$5.01B
$223K ﹤0.01%
6,224
-61,380
-91% -$2.08M
HBM icon
1024
Hudbay
HBM
$12.3B
$222K ﹤0.01%
+40,900
New +$242K
HTT
1025
High Templar Tech Ltd
HTT
$391M
$222K ﹤0.01%
+29,629
New +$204K
39 40
41
42 43

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.